Lexpos News

/Lexpos News

7 products added to the Discount Not Deducted (DND) list from February 2025

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 7 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 February 2025. This takes the total [...]

The post 7 products added to the Discount Not Deducted (DND) list from February 2025 appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on 7 products added to the Discount Not Deducted (DND) list from February 2025

Reflections on Pharmacy First: One Year On

The post Reflections on Pharmacy First: One Year On appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Reflections on Pharmacy First: One Year On

Expiry of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 250mg/5ml oral suspension sugar free is now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP078 Cefalexin 250mg/5ml oral suspension sugar free expires at 23.59pm on Friday 31 January 2025. After this date, any prescriptions [...]

The post Expiry of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Expiry of SSP078 for Cefalexin 250mg/5ml oral suspension sugar free

Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments

As part of our Funding & Reimbursement Shorts series Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments. In our latest video, Mitesh Bhudia and Gemma Hackett from our Dispensing and Supply Team, discuss the [...]

The post Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments appeared first on Community Pharmacy England.

By |January 31st, 2025|Lexpos News|Comments Off on Funding & Reimbursement Shorts: ‘FS’ endorsed prescriptions for free supply of sexual health treatments

MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)

Drug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017 [...]

The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

By |January 30th, 2025|Lexpos News|Comments Off on MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited)